Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:6-(hexylthio)-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydro-1H-pyridine-5-carbonitrile
go back to main search page
Accession:CHEBI:122203 term browser browse the term
Definition:A phenol that has formula C18H22N2O2S.
Synonyms:related_synonym: Formula=C18H22N2O2S;   InChI=1S/C18H22N2O2S/c1-2-3-4-5-10-23-18-16(12-19)15(11-17(22)20-18)13-6-8-14(21)9-7-13/h6-9,15,21H,2-5,10-11H2,1H3,(H,20,22);   InChIKey=HYBLKCYMQMUZPK-UHFFFAOYSA-N;   SMILES=CCCCCCSC1=C(C(CC(=O)N1)C2=CC=C(C=C2)O)C#N
 xref: LINCS:LSM-33646


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 23754
    chemical entity 23717
      molecular entity 23664
        polyatomic entity 23570
          heteroatomic molecular entity 23134
            hydroxides 21980
              organic hydroxy compound 20338
                phenols 18946
                  6-(hexylthio)-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydro-1H-pyridine-5-carbonitrile 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 23754
    subatomic particle 23703
      composite particle 23703
        hadron 23703
          baryon 23703
            nucleon 23703
              atomic nucleus 23703
                atom 23703
                  main group element atom 23522
                    p-block element atom 23522
                      carbon group element atom 23232
                        carbon atom 23208
                          organic molecular entity 23208
                            organic molecule 23069
                              organic cyclic compound 22086
                                organic aromatic compound 21646
                                  phenols 18946
                                    6-(hexylthio)-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydro-1H-pyridine-5-carbonitrile 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.